Economic Assessment of Adjustable Maintenance Treatment with Budesonide/Formoterol in a Single Inhaler versus Fixed Treatment in Asthma

Author： Brüggenjürgen Bernd  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.7, 2005-01, pp. : 723-731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Budesonide/formoterol for the treatment of asthma

By Buhl Roland  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1393-1406

Informa Healthcare

Access to resources Recommend Favorite

Budesonide/formoterol single inhaler therapy superior in asthma

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

By Johansson Gunnar  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 695-708

Adis International

Access to resources Recommend Favorite

Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma

By Ankerst J.   Persson G.   Weibull E.  

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 3, 2003-06 ,pp. : 147-151

Elsevier

Access to resources Recommend Favorite

Budesonide/formoterol: fixed combination therapy simpler for asthma treatment?

By  

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite